DailyMed - LBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 FM CLAIRE 1 - BEIGE- octinoxate and titanium dioxide lotion LBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 FM CLAIRE 2 - BEIGE- octinoxate and titanium dioxide lotion LBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 FM CLAIRE 3 - BEIGE- octinoxate and titanium dioxide lotion LBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 FM CLAIRE 4 - BEIGE- octinoxate and titanium dioxide lotion LBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 FM MEDIUM 5 - BEIGE- octinoxate and titanium dioxide lotion LBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 FM MEDIUM 6 - BEIGE- octinoxate and titanium dioxide lotion LBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 FM MEDIUM 7 - BEIGE- octinoxate and titanium dioxide lotion LBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 FM OBSCURE 8 - BROWN- octinoxate and titanium dioxide lotion LBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 FM OBSCURE 9 - BROWN- octinoxate and titanium dioxide lotion

Contains inactivated NDC Code(s)
NDC Code(s): 43596-0691-1, 43596-0691-2, 43596-0692-1, 43596-0692-2, view more
43596-0693-1, 43596-0693-2, 43596-0694-1, 43596-0694-2, 43596-0695-1, 43596-0695-2, 43596-0696-1, 43596-0696-2, 43596-0697-1, 43596-0697-2, 43596-0699-1, 43596-0699-2, 43596-0700-1, 43596-0700-2
Packager: Ventura Corporation LTD

Category: HUMAN OTC DRUG LABEL
DEA Schedule: None
Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated December 3, 2019

If you are a consumer or patient please visit this version.

Download DRUG LABEL INFO: PDF XML
Official Label (Printer Friendly)

View All Sections

SPL UNCLASSIFIED SECTION

Drug Facts
ACTIVE INGREDIENT

Active Ingredients Purpose

OCTINOXATE 7.00%, Sunscreen

TITANIUM DIOXIDE 2.44% Sunscreen
Uses
- Helps prevent sunburn
Warnings
- Skin Cancer / Skin Aging Alert; Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to help prevent sunburn, not skin cancer or early skin aging.
- For external use only.
- Do not use on damage or broken skin.
- When using this product keep out of eyes. Rinse with water to remove.
- Stop use and ask a doctor if rash occurs.
- Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Directions
- Apply liberally and evenly 15 minutes before sun exposure.
- Children under 6 months of age: Ask a doctor.
- Reapply at least every 2 hours.
- Use a water resistant sunscreen if swimming or sweating.
Other information
- Protect the product in this container from excessive heat and direct sun.
Inactive ingredients

WATER, CYCLOPENTASILOXANE, POLYMETHYL METHACRYLATE, DIMETHICONE, CYCLOHEXASILOXANE, CETYL PEG/PPG-10/1 DIMETHICONE, POLYGLYCERYL-4 ISOSTEARATE, HEXYL LAURATE, TRIMETHYLSILOXYSILICATE, GLYCERIN, SODIUM CHLORIDE, PEG/PPG-19/19 DIMETHICONE, HYDROXYACETOPHENONE, PHENOXYETHANOL, COFFEA ARABICA (COFFEE) SEEDCAKE EXTRACT, PEG/PPG-18/18 DIMETHICONE, ALUMINA, BUTYLENE GLYCOL, OCTYLDODECANOL, CAPRYLYL GLYCOL, TOCOPHERYL ACETATE, CHLORPHENESIN, HYDROGEN DIMETHICONE, BHT, BENZYL ALCOHOL, POTASSIUM SORBATE, CARBOMER, POLYSORBATE 20, PALMITOYL TRIPEPTIDE-1, PALMITOYL TETRAPEPTIDE-7.

MAY CONTAIN:
TITANIUM DIOXIDE, IRON OXIDES, TRIETHOXYCAPRYLYLSILANE.
SPL UNCLASSIFIED SECTION

Dist. by Ventura Corp,
Ltd., San Juan, Puerto Rico 00926.
PRINCIPAL DISPLAY PANEL - 30 ml Bottle Box - CLAIRE 1 - BEIGE

L'BEL

EFFET
PARFAIT

signs of age
appearance
minimizer
foundation
SPF 20 FM

1 fl.oz. e (30 ml)
PRINCIPAL DISPLAY PANEL - 30 ml Bottle Box - CLAIRE 2 - BEIGE

L'BEL

EFFET
PARFAIT

signs of age
appearance
minimizer
foundation
SPF 20 FM

1 fl.oz. e (30 ml)
PRINCIPAL DISPLAY PANEL - 30 ml Bottle Box - CLAIRE 3 - BEIGE

L'BEL

EFFET
PARFAIT

signs of age
appearance
minimizer
foundation
SPF 20 FM

1 fl.oz. e (30 ml)
PRINCIPAL DISPLAY PANEL - 30 ml Bottle Box - CLAIRE 4 - BEIGE

L'BEL

EFFET
PARFAIT

signs of age
appearance
minimizer
foundation
SPF 20 FM

1 fl.oz. e (30 ml)
PRINCIPAL DISPLAY PANEL - 30 ml Bottle Box - MEDIUM 5 - BEIGE

L'BEL

EFFET
PARFAIT

signs of age
appearance
minimizer
foundation
SPF 20 FM

1 fl.oz. e (30 ml)
PRINCIPAL DISPLAY PANEL - 30 ml Bottle Box - MEDIUM 6 - BEIGE

L'BEL

EFFET
PARFAIT

signs of age
appearance
minimizer
foundation
SPF 20 FM

1 fl.oz. e (30 ml)
PRINCIPAL DISPLAY PANEL - 30 ml Bottle Box - MEDIUM 7 - BEIGE

L'BEL

EFFET
PARFAIT

signs of age
appearance
minimizer
foundation
SPF 20 FM

1 fl.oz. e (30 ml)
PRINCIPAL DISPLAY PANEL - 30 ml Bottle Box - OBSCURE 8 - BROWN

L'BEL

EFFET
PARFAIT

signs of age
appearance
minimizer
foundation
SPF 20 FM

1 fl.oz. e (30 ml)
PRINCIPAL DISPLAY PANEL - 30 ml Bottle Box - OBSCURE 9 - BROWN

L'BEL

EFFET
PARFAIT

signs of age
appearance
minimizer
foundation
SPF 20 FM

1 fl.oz. e (30 ml)

Active Ingredients	Purpose
OCTINOXATE 7.00%,	Sunscreen
TITANIUM DIOXIDE 2.44%	Sunscreen

INGREDIENTS AND APPEARANCE

LBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 FM CLAIRE 1 - BEIGE
octinoxate and titanium dioxide lotion

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:43596-0691
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51)	Octinoxate	0.07 g in 1 mL
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	0.0244 g in 1 mL

Ingredient Name	Strength
Inactive Ingredients
WATER (UNII: 059QF0KO0R)
CYCLOMETHICONE 5 (UNII: 0THT5PCI0R)
DIMETHICONE (UNII: 92RU3N3Y1O)
CYCLOMETHICONE 6 (UNII: XHK3U310BA)
POLYGLYCERYL-4 ISOSTEARATE (UNII: 820DPX33S7)
HEXYL LAURATE (UNII: 4CG9F9W01Q)
GLYCERIN (UNII: PDC6A3C0OX)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
PEG/PPG-19/19 DIMETHICONE (UNII: EHH90CO7TL)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
COFFEE BEAN (UNII: JFH385Y744)
PEG/PPG-18/18 DIMETHICONE (UNII: 9H0AO7T794)
ALUMINUM OXIDE (UNII: LMI26O6933)
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
OCTYLDODECANOL (UNII: 461N1O614Y)
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
CHLORPHENESIN (UNII: I670DAL4SZ)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
BENZYL ALCOHOL (UNII: LKG8494WBH)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
CARBOXYPOLYMETHYLENE (UNII: 0A5MM307FC)
POLYSORBATE 20 (UNII: 7T1F30V5YH)
PALMITOYL TRIPEPTIDE-1 (UNII: RV743D216M)
PALMITOYL TETRAPEPTIDE-7 (UNII: Q41S464P1R)
FERRIC OXIDE RED (UNII: 1K09F3G675)
TRIETHOXYCAPRYLYLSILANE (UNII: LDC331P08E)
HYDROGEN DIMETHICONE (13 CST) (UNII: 4QGR4P2YOI)

#	Item Code	Package Description	Marketing Start Date
Packaging
1	NDC:43596-0691-2	1 in 1 BOX	12/02/2019
1	NDC:43596-0691-1	30 mL in 1 BOTTLE; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH FINAL	part352	12/02/2019

LBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 FM CLAIRE 2 - BEIGE
octinoxate and titanium dioxide lotion

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:43596-0692
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51)	Octinoxate	0.07 g in 1 mL
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	0.0244 g in 1 mL

Ingredient Name	Strength
Inactive Ingredients
WATER (UNII: 059QF0KO0R)
CYCLOMETHICONE 5 (UNII: 0THT5PCI0R)
DIMETHICONE (UNII: 92RU3N3Y1O)
CYCLOMETHICONE 6 (UNII: XHK3U310BA)
POLYGLYCERYL-4 ISOSTEARATE (UNII: 820DPX33S7)
HEXYL LAURATE (UNII: 4CG9F9W01Q)
GLYCERIN (UNII: PDC6A3C0OX)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
PEG/PPG-19/19 DIMETHICONE (UNII: EHH90CO7TL)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
COFFEE BEAN (UNII: JFH385Y744)
PEG/PPG-18/18 DIMETHICONE (UNII: 9H0AO7T794)
ALUMINUM OXIDE (UNII: LMI26O6933)
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
OCTYLDODECANOL (UNII: 461N1O614Y)
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
CHLORPHENESIN (UNII: I670DAL4SZ)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
BENZYL ALCOHOL (UNII: LKG8494WBH)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
CARBOXYPOLYMETHYLENE (UNII: 0A5MM307FC)
POLYSORBATE 20 (UNII: 7T1F30V5YH)
PALMITOYL TRIPEPTIDE-1 (UNII: RV743D216M)
PALMITOYL TETRAPEPTIDE-7 (UNII: Q41S464P1R)
FERRIC OXIDE RED (UNII: 1K09F3G675)
TRIETHOXYCAPRYLYLSILANE (UNII: LDC331P08E)
HYDROGEN DIMETHICONE (13 CST) (UNII: 4QGR4P2YOI)

#	Item Code	Package Description	Marketing Start Date
Packaging
1	NDC:43596-0692-2	1 in 1 BOX	12/02/2019
1	NDC:43596-0692-1	30 mL in 1 BOTTLE; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH FINAL	part352	12/02/2019

LBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 FM CLAIRE 3 - BEIGE
octinoxate and titanium dioxide lotion

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:43596-0693
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51)	Octinoxate	0.07 g in 1 mL
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	0.0244 g in 1 mL

Ingredient Name	Strength
Inactive Ingredients
WATER (UNII: 059QF0KO0R)
CYCLOMETHICONE 5 (UNII: 0THT5PCI0R)
DIMETHICONE (UNII: 92RU3N3Y1O)
CYCLOMETHICONE 6 (UNII: XHK3U310BA)
POLYGLYCERYL-4 ISOSTEARATE (UNII: 820DPX33S7)
HEXYL LAURATE (UNII: 4CG9F9W01Q)
GLYCERIN (UNII: PDC6A3C0OX)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
PEG/PPG-19/19 DIMETHICONE (UNII: EHH90CO7TL)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
COFFEE BEAN (UNII: JFH385Y744)
PEG/PPG-18/18 DIMETHICONE (UNII: 9H0AO7T794)
ALUMINUM OXIDE (UNII: LMI26O6933)
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
OCTYLDODECANOL (UNII: 461N1O614Y)
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
CHLORPHENESIN (UNII: I670DAL4SZ)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
BENZYL ALCOHOL (UNII: LKG8494WBH)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
CARBOXYPOLYMETHYLENE (UNII: 0A5MM307FC)
POLYSORBATE 20 (UNII: 7T1F30V5YH)
PALMITOYL TRIPEPTIDE-1 (UNII: RV743D216M)
PALMITOYL TETRAPEPTIDE-7 (UNII: Q41S464P1R)
FERRIC OXIDE RED (UNII: 1K09F3G675)
TRIETHOXYCAPRYLYLSILANE (UNII: LDC331P08E)
HYDROGEN DIMETHICONE (13 CST) (UNII: 4QGR4P2YOI)

#	Item Code	Package Description	Marketing Start Date
Packaging
1	NDC:43596-0693-2	1 in 1 BOX	12/02/2019
1	NDC:43596-0693-1	30 mL in 1 BOTTLE; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH FINAL	part352	12/02/2019

LBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 FM CLAIRE 4 - BEIGE
octinoxate and titanium dioxide lotion

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:43596-0694
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51)	Octinoxate	0.07 g in 1 mL
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	0.0244 g in 1 mL

Ingredient Name	Strength
Inactive Ingredients
WATER (UNII: 059QF0KO0R)
CYCLOMETHICONE 5 (UNII: 0THT5PCI0R)
DIMETHICONE (UNII: 92RU3N3Y1O)
CYCLOMETHICONE 6 (UNII: XHK3U310BA)
POLYGLYCERYL-4 ISOSTEARATE (UNII: 820DPX33S7)
HEXYL LAURATE (UNII: 4CG9F9W01Q)
GLYCERIN (UNII: PDC6A3C0OX)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
PEG/PPG-19/19 DIMETHICONE (UNII: EHH90CO7TL)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
COFFEE BEAN (UNII: JFH385Y744)
PEG/PPG-18/18 DIMETHICONE (UNII: 9H0AO7T794)
ALUMINUM OXIDE (UNII: LMI26O6933)
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
OCTYLDODECANOL (UNII: 461N1O614Y)
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
CHLORPHENESIN (UNII: I670DAL4SZ)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
BENZYL ALCOHOL (UNII: LKG8494WBH)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
CARBOXYPOLYMETHYLENE (UNII: 0A5MM307FC)
POLYSORBATE 20 (UNII: 7T1F30V5YH)
PALMITOYL TRIPEPTIDE-1 (UNII: RV743D216M)
PALMITOYL TETRAPEPTIDE-7 (UNII: Q41S464P1R)
FERRIC OXIDE RED (UNII: 1K09F3G675)
TRIETHOXYCAPRYLYLSILANE (UNII: LDC331P08E)
HYDROGEN DIMETHICONE (13 CST) (UNII: 4QGR4P2YOI)

#	Item Code	Package Description	Marketing Start Date
Packaging
1	NDC:43596-0694-2	1 in 1 BOX	12/02/2019
1	NDC:43596-0694-1	30 mL in 1 BOTTLE; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH FINAL	part352	12/02/2019

LBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 FM MEDIUM 5 - BEIGE
octinoxate and titanium dioxide lotion

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:43596-0695
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51)	Octinoxate	0.07 g in 1 mL
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	0.0244 g in 1 mL

Ingredient Name	Strength
Inactive Ingredients
WATER (UNII: 059QF0KO0R)
CYCLOMETHICONE 5 (UNII: 0THT5PCI0R)
DIMETHICONE (UNII: 92RU3N3Y1O)
CYCLOMETHICONE 6 (UNII: XHK3U310BA)
POLYGLYCERYL-4 ISOSTEARATE (UNII: 820DPX33S7)
HEXYL LAURATE (UNII: 4CG9F9W01Q)
GLYCERIN (UNII: PDC6A3C0OX)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
PEG/PPG-19/19 DIMETHICONE (UNII: EHH90CO7TL)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
COFFEE BEAN (UNII: JFH385Y744)
PEG/PPG-18/18 DIMETHICONE (UNII: 9H0AO7T794)
ALUMINUM OXIDE (UNII: LMI26O6933)
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
OCTYLDODECANOL (UNII: 461N1O614Y)
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
CHLORPHENESIN (UNII: I670DAL4SZ)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
BENZYL ALCOHOL (UNII: LKG8494WBH)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
CARBOXYPOLYMETHYLENE (UNII: 0A5MM307FC)
POLYSORBATE 20 (UNII: 7T1F30V5YH)
PALMITOYL TRIPEPTIDE-1 (UNII: RV743D216M)
PALMITOYL TETRAPEPTIDE-7 (UNII: Q41S464P1R)
FERRIC OXIDE RED (UNII: 1K09F3G675)
TRIETHOXYCAPRYLYLSILANE (UNII: LDC331P08E)
HYDROGEN DIMETHICONE (13 CST) (UNII: 4QGR4P2YOI)

#	Item Code	Package Description	Marketing Start Date
Packaging
1	NDC:43596-0695-2	1 in 1 BOX	12/02/2019
1	NDC:43596-0695-1	30 mL in 1 BOTTLE; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH FINAL	part352	12/02/2019

LBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 FM MEDIUM 6 - BEIGE
octinoxate and titanium dioxide lotion

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:43596-0696
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51)	Octinoxate	0.07 g in 1 mL
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	0.0244 g in 1 mL

Ingredient Name	Strength
Inactive Ingredients
WATER (UNII: 059QF0KO0R)
CYCLOMETHICONE 5 (UNII: 0THT5PCI0R)
DIMETHICONE (UNII: 92RU3N3Y1O)
CYCLOMETHICONE 6 (UNII: XHK3U310BA)
POLYGLYCERYL-4 ISOSTEARATE (UNII: 820DPX33S7)
HEXYL LAURATE (UNII: 4CG9F9W01Q)
GLYCERIN (UNII: PDC6A3C0OX)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
PEG/PPG-19/19 DIMETHICONE (UNII: EHH90CO7TL)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
COFFEE BEAN (UNII: JFH385Y744)
PEG/PPG-18/18 DIMETHICONE (UNII: 9H0AO7T794)
ALUMINUM OXIDE (UNII: LMI26O6933)
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
OCTYLDODECANOL (UNII: 461N1O614Y)
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
CHLORPHENESIN (UNII: I670DAL4SZ)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
BENZYL ALCOHOL (UNII: LKG8494WBH)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
CARBOXYPOLYMETHYLENE (UNII: 0A5MM307FC)
POLYSORBATE 20 (UNII: 7T1F30V5YH)
PALMITOYL TRIPEPTIDE-1 (UNII: RV743D216M)
PALMITOYL TETRAPEPTIDE-7 (UNII: Q41S464P1R)
FERRIC OXIDE RED (UNII: 1K09F3G675)
TRIETHOXYCAPRYLYLSILANE (UNII: LDC331P08E)
HYDROGEN DIMETHICONE (13 CST) (UNII: 4QGR4P2YOI)

#	Item Code	Package Description	Marketing Start Date
Packaging
1	NDC:43596-0696-2	1 in 1 BOX	12/02/2019
1	NDC:43596-0696-1	30 mL in 1 BOTTLE; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH FINAL	part352	12/02/2019

LBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 FM MEDIUM 7 - BEIGE
octinoxate and titanium dioxide lotion

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:43596-0697
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51)	Octinoxate	0.07 g in 1 mL
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	0.0244 g in 1 mL

Ingredient Name	Strength
Inactive Ingredients
WATER (UNII: 059QF0KO0R)
CYCLOMETHICONE 5 (UNII: 0THT5PCI0R)
DIMETHICONE (UNII: 92RU3N3Y1O)
CYCLOMETHICONE 6 (UNII: XHK3U310BA)
POLYGLYCERYL-4 ISOSTEARATE (UNII: 820DPX33S7)
HEXYL LAURATE (UNII: 4CG9F9W01Q)
GLYCERIN (UNII: PDC6A3C0OX)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
PEG/PPG-19/19 DIMETHICONE (UNII: EHH90CO7TL)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
COFFEE BEAN (UNII: JFH385Y744)
PEG/PPG-18/18 DIMETHICONE (UNII: 9H0AO7T794)
ALUMINUM OXIDE (UNII: LMI26O6933)
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
OCTYLDODECANOL (UNII: 461N1O614Y)
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
CHLORPHENESIN (UNII: I670DAL4SZ)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
BENZYL ALCOHOL (UNII: LKG8494WBH)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
CARBOXYPOLYMETHYLENE (UNII: 0A5MM307FC)
POLYSORBATE 20 (UNII: 7T1F30V5YH)
PALMITOYL TRIPEPTIDE-1 (UNII: RV743D216M)
PALMITOYL TETRAPEPTIDE-7 (UNII: Q41S464P1R)
FERRIC OXIDE RED (UNII: 1K09F3G675)
TRIETHOXYCAPRYLYLSILANE (UNII: LDC331P08E)
HYDROGEN DIMETHICONE (13 CST) (UNII: 4QGR4P2YOI)

#	Item Code	Package Description	Marketing Start Date
Packaging
1	NDC:43596-0697-2	1 in 1 BOX	12/02/2019
1	NDC:43596-0697-1	30 mL in 1 BOTTLE; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH FINAL	part352	12/02/2019

LBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 FM OBSCURE 8 - BROWN
octinoxate and titanium dioxide lotion

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:43596-0699
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51)	Octinoxate	0.07 g in 1 mL
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	0.0244 g in 1 mL

Ingredient Name	Strength
Inactive Ingredients
WATER (UNII: 059QF0KO0R)
CYCLOMETHICONE 5 (UNII: 0THT5PCI0R)
DIMETHICONE (UNII: 92RU3N3Y1O)
CYCLOMETHICONE 6 (UNII: XHK3U310BA)
POLYGLYCERYL-4 ISOSTEARATE (UNII: 820DPX33S7)
HEXYL LAURATE (UNII: 4CG9F9W01Q)
GLYCERIN (UNII: PDC6A3C0OX)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
PEG/PPG-19/19 DIMETHICONE (UNII: EHH90CO7TL)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
COFFEE BEAN (UNII: JFH385Y744)
PEG/PPG-18/18 DIMETHICONE (UNII: 9H0AO7T794)
ALUMINUM OXIDE (UNII: LMI26O6933)
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
OCTYLDODECANOL (UNII: 461N1O614Y)
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
CHLORPHENESIN (UNII: I670DAL4SZ)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
BENZYL ALCOHOL (UNII: LKG8494WBH)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
CARBOXYPOLYMETHYLENE (UNII: 0A5MM307FC)
POLYSORBATE 20 (UNII: 7T1F30V5YH)
PALMITOYL TRIPEPTIDE-1 (UNII: RV743D216M)
PALMITOYL TETRAPEPTIDE-7 (UNII: Q41S464P1R)
FERRIC OXIDE RED (UNII: 1K09F3G675)
TRIETHOXYCAPRYLYLSILANE (UNII: LDC331P08E)
HYDROGEN DIMETHICONE (13 CST) (UNII: 4QGR4P2YOI)

#	Item Code	Package Description	Marketing Start Date
Packaging
1	NDC:43596-0699-2	1 in 1 BOX	12/02/2019
1	NDC:43596-0699-1	30 mL in 1 BOTTLE; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH FINAL	part352	12/02/2019

LBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 FM OBSCURE 9 - BROWN
octinoxate and titanium dioxide lotion

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:43596-0700
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51)	Octinoxate	0.07 g in 1 mL
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	0.0244 g in 1 mL

Ingredient Name	Strength
Inactive Ingredients
WATER (UNII: 059QF0KO0R)
CYCLOMETHICONE 5 (UNII: 0THT5PCI0R)
DIMETHICONE (UNII: 92RU3N3Y1O)
CYCLOMETHICONE 6 (UNII: XHK3U310BA)
POLYGLYCERYL-4 ISOSTEARATE (UNII: 820DPX33S7)
HEXYL LAURATE (UNII: 4CG9F9W01Q)
GLYCERIN (UNII: PDC6A3C0OX)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
PEG/PPG-19/19 DIMETHICONE (UNII: EHH90CO7TL)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
COFFEE BEAN (UNII: JFH385Y744)
PEG/PPG-18/18 DIMETHICONE (UNII: 9H0AO7T794)
ALUMINUM OXIDE (UNII: LMI26O6933)
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
OCTYLDODECANOL (UNII: 461N1O614Y)
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
CHLORPHENESIN (UNII: I670DAL4SZ)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
BENZYL ALCOHOL (UNII: LKG8494WBH)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
CARBOXYPOLYMETHYLENE (UNII: 0A5MM307FC)
POLYSORBATE 20 (UNII: 7T1F30V5YH)
PALMITOYL TRIPEPTIDE-1 (UNII: RV743D216M)
PALMITOYL TETRAPEPTIDE-7 (UNII: Q41S464P1R)
FERRIC OXIDE RED (UNII: 1K09F3G675)
TRIETHOXYCAPRYLYLSILANE (UNII: LDC331P08E)
HYDROGEN DIMETHICONE (13 CST) (UNII: 4QGR4P2YOI)

#	Item Code	Package Description	Marketing Start Date
Packaging
1	NDC:43596-0700-2	1 in 1 BOX	12/02/2019
1	NDC:43596-0700-1	30 mL in 1 BOTTLE; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC MONOGRAPH FINAL	part352	12/02/2019

Labeler - Ventura Corporation LTD (602751344)

Name	Address	ID/FEI	Business Operations
Establishment
Bel Star S.A. (Colombia)		880160197	MANUFACTURE(43596-0691, 43596-0692, 43596-0693, 43596-0694, 43596-0695, 43596-0696, 43596-0697, 43596-0699, 43596-0700)

View All Sections

View Package Photos

VIEW MORE

Drug Label Info

Safety

Related Resources

More Info For This Drug

Drug Label Information

Find additional resources

Safety

Related Resources

More Info on this Drug

	NDC
1	43596-0691-1
2	43596-0691-2 (inactivated)
3	43596-0692-1
4	43596-0692-2 (inactivated)
5	43596-0693-1
6	43596-0693-2 (inactivated)
7	43596-0694-1
8	43596-0694-2 (inactivated)
9	43596-0695-1
10	43596-0695-2 (inactivated)
11	43596-0696-1
12	43596-0696-2 (inactivated)
13	43596-0697-1
14	43596-0697-2 (inactivated)
15	43596-0699-1
16	43596-0699-2 (inactivated)
17	43596-0700-1
18	43596-0700-2 (inactivated)

View Package Photos

VIEW MORE

Drug Label Info

Safety

Related Resources

More Info For This Drug

Drug Label Information

Find additional resources

Safety

Related Resources

More Info on this Drug

Number of versions: 1

To receive this label RSS feed

To receive all DailyMed Updates for the last seven days

What will I get with the DailyMed RSS feed?

How to discontinue the RSS feed

Why is DailyMed no longer displaying pill images on the Search Results and Drug Info pages?

If this SPL contains inactivated NDCs listed by the FDA initiated compliance action, they will be specified as such.